Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma
- PMID: 38534992
- PMCID: PMC10969450
- DOI: 10.3390/diagnostics14060571
Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma
Abstract
The purpose of this study was to evaluate whether intravoxel incoherent motion (IVIM) parameters can enhance the diagnostic performance of MRI in differentiating normal pancreatic parenchyma from solid pancreatic adenocarcinomas. This study included 113 participants: 66 patients diagnosed with pancreatic adenocarcinoma and 47 healthy volunteers. An MRI was conducted at 1.5 T MR unit, using nine b-values. Postprocessing involved analyzing both conventional monoexponential apparent diffusion coefficient (ADC) and IVIM parameters (diffusion coefficient D-pure molecular diffusion coefficient, perfusion-dependent diffusion coefficient D*-pseudodiffusion coeffitient, and perfusion fraction coefficient (f)) across four different b-value selections. Significantly higher parameters were found in the control group when using high b-values for the pure diffusion analysis and all b-values for the monoexponential analysis. Conversely, in the study group, the parameters were affected by low b-values. Most parameters could differentiate between normal and cancerous tissue, with D* showing the highest diagnostic performance (AUC 98-100%). A marked decrease in perfusion in the patients with pancreatic cancer, indicated by the significant differences in the D* medians between groups, was found. In conclusion, standard ADC maps alone may not suffice for a definitive pancreatic cancer diagnosis, and incorporating IVIM into MRI protocols is recommended, as the reduced tissue perfusion detected by the IVIM parameters is a promising marker for pancreatic adenocarcinoma.
Keywords: diagnostic accuracy; diffusion-weighted imaging; intravoxel incoherent motion; pancreatic ductal adenocarcinoma; perfusion-dependent diffusion coefficient.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma.Eur Radiol. 2018 Jul;28(7):2781-2789. doi: 10.1007/s00330-017-5259-0. Epub 2018 Feb 5. Eur Radiol. 2018. PMID: 29404768
-
The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.Eur J Radiol. 2022 May;150:110261. doi: 10.1016/j.ejrad.2022.110261. Epub 2022 Mar 17. Eur J Radiol. 2022. PMID: 35316674
-
Evaluating the Histopathology of Pancreatic Ductal Adenocarcinoma by Intravoxel Incoherent Motion-Diffusion Weighted Imaging Comparing With Diffusion-Weighted Imaging.Front Oncol. 2021 Jun 23;11:670085. doi: 10.3389/fonc.2021.670085. eCollection 2021. Front Oncol. 2021. PMID: 34249707 Free PMC article.
-
Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Quantitative Differentiation of Breast Tumors: A Meta-Analysis.Front Oncol. 2020 Oct 20;10:585486. doi: 10.3389/fonc.2020.585486. eCollection 2020. Front Oncol. 2020. PMID: 33194733 Free PMC article.
-
Intravoxel Incoherent Motion Diffusion-Weighted Imaging Used to Detect Prostate Cancer and Stratify Tumor Grade: A Meta-Analysis.Front Oncol. 2020 Sep 11;10:1623. doi: 10.3389/fonc.2020.01623. eCollection 2020. Front Oncol. 2020. PMID: 33042805 Free PMC article.
References
LinkOut - more resources
Full Text Sources